Lung neoplasmsNeoadjuvant therapyTargeted therapyIn this article, we summarize our personal non-small cell lung cancer (NSCLC) highlights from the ESMO 2022 meeting, covering developments in early- and advanced-stage NSCLC. In early-stage disease, many studies underlined possibilities of neoadjuvant and...
问题1:是否有必要检测所有具有临床实用性的(包括常见和非典型/罕见)EGFR突变? 共识:推荐检测EGFR基因18、19、20、21外显子上所有确定的或潜在的临床意义突变,最好是NGS(二代测序)方法。 证据水平:I,推荐等级:A。 讨论:所有非小细胞肺癌患者,不论疾病分期,均应由病理学家在最初诊断时进行全面的生物标志物检测,...
1.NCCN Guidelines Version 3.2022 Non-Small Cell Lung Cancer. 2.CT538-Tepotinib+gefitinib in patients with EGFR-mutant NSCLC with MET amplification: Final analysis of INSIGHT.2022 AACR. 作者:医世象 叶子 推荐阅读: 1. ...
1.NCCN Guidelines Version 3.2022 Non-Small Cell Lung Cancer. 2.CT538-Tepotinib+gefitinib in patients with EGFR-mutant NSCLC with MET amplification: Final analysis of INSIGHT.2022 AACR.
Scientists from the Francis Crick Institute and University College London say they have, for the first time, conclusively explained how air pollution leads to lung cancer in nonsmokers.
Furthermore, HANSIZHUANG was recommended by the 2022 CSCO Guidelines for Diagnosis and Treatment of Small Cell Lung Cancer (SCLC) for the treatment of ES-SCLC, and the related clinical trial has also become the firs...
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol, 27 (Suppl 5) (2016), pp. v1-v27 View PDFView articleCrossrefGoogle Scholar 15. N. Navani, J.N. Brown, M. Nankivell, et al. Suitability of endobronchial ultrasound-...
2020. Accessed June 20, 2022. Available at https://online.fliphtml5.com/thpbe/cljw/#p=45 Google Scholar 20 C. Parker, E. Castro, K. Fizazi, et al. Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol, 31 (9) (2020), pp. 1119-1134...
December 8th 2022 Concurrent adagrasib and pembrolizumab produced preliminary activity when administered as first-line treatment in patients with non–small cell lung cancer harboring a KRAS G12C mutation, irrespective of PD-L1 status, according to data from the KRYSTAL-1 phase 1b and the KRYSTAL...
European Lung Cancer Congress (ELCC 2022) Date: 30 March – 2 April 2022 Venue: Virtual(虚拟会议) The European Lung Cancer Congress (ELCC 2022), will be a hybrid meeting, taking place onsite in Prague, Czech Republic, from 30 March-2 April 2022, and online, through a virtual platform. ...